Monthly Archives: January 2022
Riboflavin biosynthetic pathway: A potent antitubercular drug target
- January 4, 2022
- Science News@RCB
- IT RCB
- No Comments.
Tuberculosis (TB) is one of the leading causes of death, according to the World Health Organization report a total of 1.5 million people died from TB in 2020 and its the second leading infectious killer after COVID-19 (above HIV/AIDS). TB is caused from a Mycobacterium tuberculosis (M. tuberculosis) bacterium. The increase in M. tuberculosis drug […]
Read more